National blood testing service, digital healthcare with 50% profit

For institutional and private equity buyers, only.
Please read the full description before reaching out. Serious inquiries only. Initial phone call introduction is required before signing an NDA. Seller will conduct a pre-screening of all potential buyers.

This is a high-profit business with zero debt and no inventory. In 2023, it generated $202,000 in passive gross profit, maintaining a consistent 50% profit margin since 2014—a proven, highly attractive business model! An NDA is required to receive the pitch deck.

Business Overview: A direct-to-consumer plus direct-to-doctor blood testing company with national reach, backed by a leading laboratory. ABLE TO OPERATE NATIONALLY.
Established in 2014, this digital-first company offers passive income potential with no need for an active owner. Serving hundreds of providers and consumers across the U.S., the company operates with no overhead, no W2 employees, and zero debt.

Key Details:

Two business segments: Direct-to-Consumer and Direct-to-Provider
Presence in all 50 U.S. states
The lowest cost for on-demand blood testing, performing thousands of tests monthly
Exclusive, robust contract with a lab vendor, making the business model unique and difficult to replicate
Major growth potential, with the capacity to scale up to $15M annually
Offerings:

Access to 8,500 blood tests and 2,500 patient service centers nationwide
Supported by a leading laboratory for comprehensive diagnostic testing
Minimal operational expenses. CONTACT US FOR MORE INFORMATION